Korea Arlico Pharm Co.,Ltd. (KOSDAQ:A260660) announces a share repurchase program. Under the program, the company will repurchase up to 102,040 shares. The purpose behind the program is to improve shareholder value and to stabilize stock price. The repurchase program will expire on June 13, 2020. As of March 12, 2020, the company had 143,534 treasury shares within scope available for dividend and no shares in treasury through other repurchase.